Annual FCF
-$7.09 M
+$1.09 M+13.31%
31 December 2023
Summary:
Titan Pharmaceuticals annual free cash flow is currently -$7.09 million, with the most recent change of +$1.09 million (+13.31%) on 31 December 2023. During the last 3 years, it has risen by +$828.00 thousand (+10.45%). TTNP annual FCF is now -204.32% below its all-time high of $6.80 million, reached on 31 December 1997.TTNP Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$2.07 M
-$1.46 M-237.36%
30 June 2024
Summary:
Titan Pharmaceuticals quarterly free cash flow is currently -$2.07 million, with the most recent change of -$1.46 million (-237.36%) on 30 June 2024. Over the past year, it has increased by +$178.00 thousand (+7.93%). TTNP quarterly FCF is now -114.99% below its all-time high of $13.80 million, reached on 31 December 1997.TTNP Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$6.76 M
-$956.00 K-16.47%
30 June 2024
Summary:
Titan Pharmaceuticals TTM free cash flow is currently -$6.76 million, with the most recent change of -$956.00 thousand (-16.47%) on 30 June 2024. Over the past year, it has increased by +$330.00 thousand (+4.65%). TTNP TTM FCF is now -186.93% below its all-time high of $7.78 million, reached on 30 June 2016.TTNP TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTNP Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +7.9% | +4.7% |
| 3 y3 years | +10.4% | -90.4% | +14.6% |
| 5 y5 years | +54.8% | +45.2% | +56.9% |
TTNP Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +13.3% | -237.4% | +30.2% | -16.5% | +18.1% |
| 5 y | 5 years | at high | +60.0% | -237.4% | +60.5% | -16.5% | +61.9% |
| alltime | all time | -204.3% | +76.4% | -115.0% | +74.7% | -186.9% | +77.5% |
Titan Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$2.07 M(+237.4%) | -$6.76 M(+16.5%) |
| Mar 2024 | - | -$613.00 K(-72.7%) | -$5.81 M(-18.1%) |
| Dec 2023 | -$7.09 M(-13.3%) | -$2.25 M(+22.4%) | -$7.09 M(+10.4%) |
| Sept 2023 | - | -$1.83 M(+65.0%) | -$6.42 M(-0.6%) |
| June 2023 | - | -$1.11 M(-41.4%) | -$6.46 M(-9.2%) |
| Mar 2023 | - | -$1.90 M(+20.3%) | -$7.12 M(-13.0%) |
| Dec 2022 | -$8.18 M(+3.3%) | -$1.58 M(-15.7%) | -$8.18 M(+6.4%) |
| Sept 2022 | - | -$1.87 M(+6.0%) | -$7.69 M(-4.8%) |
| June 2022 | - | -$1.77 M(-40.4%) | -$8.08 M(-2.2%) |
| Mar 2022 | - | -$2.96 M(+172.9%) | -$8.26 M(+4.3%) |
| Dec 2021 | -$7.92 M(-55.4%) | -$1.09 M(-52.0%) | -$7.92 M(-30.5%) |
| Sept 2021 | - | -$2.26 M(+16.1%) | -$11.41 M(-12.5%) |
| June 2021 | - | -$1.95 M(-25.8%) | -$13.04 M(-13.8%) |
| Mar 2021 | - | -$2.63 M(-42.6%) | -$15.13 M(-14.7%) |
| Dec 2020 | -$17.74 M(+13.0%) | -$4.57 M(+17.5%) | -$17.74 M(+4.7%) |
| Sept 2020 | - | -$3.89 M(-3.7%) | -$16.95 M(+3.1%) |
| June 2020 | - | -$4.04 M(-22.9%) | -$16.44 M(-0.9%) |
| Mar 2020 | - | -$5.24 M(+38.9%) | -$16.59 M(+5.7%) |
| Dec 2019 | -$15.70 M(+77.5%) | -$3.77 M(+11.5%) | -$15.70 M(+0.8%) |
| Sept 2019 | - | -$3.39 M(-19.1%) | -$15.58 M(+7.6%) |
| June 2019 | - | -$4.19 M(-3.8%) | -$14.48 M(+19.2%) |
| Mar 2019 | - | -$4.35 M(+19.1%) | -$12.14 M(+37.2%) |
| Dec 2018 | -$8.85 M(-31.2%) | -$3.65 M(+59.8%) | -$8.85 M(+1.5%) |
| Sept 2018 | - | -$2.29 M(+23.5%) | -$8.72 M(-13.7%) |
| June 2018 | - | -$1.85 M(+75.1%) | -$10.10 M(-6.2%) |
| Mar 2018 | - | -$1.06 M(-70.0%) | -$10.77 M(-16.2%) |
| Dec 2017 | -$12.85 M(-309.9%) | -$3.52 M(-4.1%) | -$12.85 M(+8.8%) |
| Sept 2017 | - | -$3.67 M(+45.8%) | -$11.81 M(+7.8%) |
| June 2017 | - | -$2.52 M(-19.6%) | -$10.96 M(-315.6%) |
| Mar 2017 | - | -$3.14 M(+26.3%) | $5.08 M(-17.0%) |
| Dec 2016 | $6.12 M(-180.6%) | -$2.48 M(-11.8%) | $6.12 M(-9.6%) |
| Sept 2016 | - | -$2.82 M(-120.8%) | $6.77 M(-12.9%) |
| June 2016 | - | $13.52 M(-745.2%) | $7.78 M(-201.5%) |
| Mar 2016 | - | -$2.10 M(+14.3%) | -$7.66 M(+0.8%) |
| Dec 2015 | -$7.60 M(+29.2%) | -$1.83 M(+1.3%) | -$7.60 M(+3.6%) |
| Sept 2015 | - | -$1.81 M(-6.0%) | -$7.34 M(+5.9%) |
| June 2015 | - | -$1.92 M(-5.4%) | -$6.93 M(+9.0%) |
| Mar 2015 | - | -$2.03 M(+29.3%) | -$6.36 M(+8.1%) |
| Dec 2014 | -$5.88 M(-41.9%) | -$1.57 M(+12.0%) | -$5.88 M(-8.6%) |
| Sept 2014 | - | -$1.40 M(+4.0%) | -$6.44 M(-10.7%) |
| June 2014 | - | -$1.35 M(-13.5%) | -$7.21 M(-26.4%) |
| Mar 2014 | - | -$1.56 M(-26.6%) | -$9.79 M(-3.2%) |
| Dec 2013 | -$10.12 M(-1596.6%) | -$2.13 M(-2.4%) | -$10.12 M(-837.4%) |
| Sept 2013 | - | -$2.18 M(-44.6%) | $1.37 M(+31.9%) |
| June 2013 | - | -$3.93 M(+108.6%) | $1.04 M(-43.7%) |
| Mar 2013 | - | -$1.88 M(-120.1%) | $1.85 M(+173.1%) |
| Dec 2012 | $676.00 K(-104.6%) | $9.36 M(-473.1%) | $676.00 K(-106.1%) |
| Sept 2012 | - | -$2.51 M(-19.7%) | -$11.05 M(-6.8%) |
| June 2012 | - | -$3.12 M(+2.3%) | -$11.86 M(-24.2%) |
| Mar 2012 | - | -$3.05 M(+29.1%) | -$15.66 M(+6.4%) |
| Dec 2011 | -$14.71 M(+214.0%) | -$2.37 M(-28.7%) | -$14.71 M(-3.9%) |
| Sept 2011 | - | -$3.32 M(-52.0%) | -$15.30 M(+29.0%) |
| June 2011 | - | -$6.92 M(+228.2%) | -$11.86 M(+131.0%) |
| Mar 2011 | - | -$2.11 M(-28.7%) | -$5.14 M(+9.6%) |
| Dec 2010 | -$4.68 M | -$2.96 M(-2544.6%) | -$4.68 M(+73.1%) |
| Sept 2010 | - | $121.00 K(-163.4%) | -$2.71 M(-32.7%) |
| June 2010 | - | -$191.00 K(-88.5%) | -$4.02 M(-26.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | -$1.66 M(+69.1%) | -$5.49 M(+1.5%) |
| Dec 2009 | -$5.41 M(-64.8%) | -$980.00 K(-18.1%) | -$5.41 M(+22.1%) |
| Sept 2009 | - | -$1.20 M(-28.0%) | -$4.43 M(-52.3%) |
| June 2009 | - | -$1.66 M(+5.3%) | -$9.30 M(-32.8%) |
| Mar 2009 | - | -$1.58 M(-74.0%) | -$13.85 M(-37.8%) |
| Sept 2008 | - | -$6.07 M(-2.4%) | -$22.27 M(+9.0%) |
| June 2008 | - | -$6.21 M(+10.0%) | -$20.43 M(+15.2%) |
| Mar 2008 | - | -$5.65 M(+29.9%) | -$17.73 M(+15.2%) |
| Dec 2007 | -$15.40 M(+13.5%) | -$4.35 M(+3.0%) | -$15.40 M(+4.5%) |
| Sept 2007 | - | -$4.22 M(+20.0%) | -$14.74 M(+8.9%) |
| June 2007 | - | -$3.52 M(+6.1%) | -$13.54 M(+10.1%) |
| Mar 2007 | - | -$3.31 M(-10.0%) | -$12.30 M(-9.3%) |
| Dec 2006 | -$13.56 M(-41.2%) | -$3.69 M(+22.1%) | -$13.56 M(-11.2%) |
| Sept 2006 | - | -$3.02 M(+32.5%) | -$15.28 M(-13.8%) |
| June 2006 | - | -$2.28 M(-50.3%) | -$17.72 M(-20.6%) |
| Mar 2006 | - | -$4.58 M(-15.2%) | -$22.32 M(-3.3%) |
| Dec 2005 | -$23.07 M(-6.4%) | -$5.40 M(-1.0%) | -$23.07 M(-5.9%) |
| Sept 2005 | - | -$5.46 M(-20.6%) | -$24.52 M(+0.4%) |
| June 2005 | - | -$6.88 M(+28.8%) | -$24.43 M(-1.4%) |
| Mar 2005 | - | -$5.34 M(-22.1%) | -$24.78 M(+0.6%) |
| Dec 2004 | -$24.64 M(-7.7%) | -$6.85 M(+27.6%) | -$24.64 M(-1.2%) |
| Sept 2004 | - | -$5.37 M(-25.7%) | -$24.95 M(-2.2%) |
| June 2004 | - | -$7.22 M(+39.2%) | -$25.50 M(+3.3%) |
| Mar 2004 | - | -$5.19 M(-27.5%) | -$24.70 M(-7.5%) |
| Dec 2003 | -$26.69 M(-11.3%) | -$7.16 M(+20.9%) | -$26.69 M(-3.7%) |
| Sept 2003 | - | -$5.92 M(-7.7%) | -$27.70 M(-6.5%) |
| June 2003 | - | -$6.42 M(-10.7%) | -$29.62 M(+1.1%) |
| Mar 2003 | - | -$7.18 M(-12.2%) | -$29.29 M(-2.6%) |
| Dec 2002 | -$30.07 M(+114.9%) | -$8.18 M(+4.3%) | -$30.07 M(+22.0%) |
| Sept 2002 | - | -$7.84 M(+28.9%) | -$24.64 M(+12.7%) |
| June 2002 | - | -$6.08 M(-23.6%) | -$21.87 M(+28.1%) |
| Mar 2002 | - | -$7.96 M(+189.3%) | -$17.07 M(+22.0%) |
| Dec 2001 | -$13.99 M(+3.4%) | -$2.75 M(-45.7%) | -$13.99 M(-7.3%) |
| Sept 2001 | - | -$5.07 M(+292.6%) | -$15.09 M(+11.3%) |
| June 2001 | - | -$1.29 M(-73.6%) | -$13.55 M(-5.1%) |
| Mar 2001 | - | -$4.88 M(+26.8%) | -$14.28 M(+5.5%) |
| Dec 2000 | -$13.54 M(+22.0%) | -$3.85 M(+9.0%) | -$13.54 M(+10.2%) |
| Sept 2000 | - | -$3.53 M(+75.1%) | -$12.29 M(+5.4%) |
| June 2000 | - | -$2.02 M(-51.3%) | -$11.66 M(-7.0%) |
| Mar 2000 | - | -$4.14 M(+59.2%) | -$12.54 M(+13.0%) |
| Dec 1999 | -$11.10 M(-17.2%) | -$2.60 M(-10.3%) | -$11.10 M(-1.8%) |
| Sept 1999 | - | -$2.90 M(0.0%) | -$11.30 M(+1.8%) |
| June 1999 | - | -$2.90 M(+7.4%) | -$11.10 M(+3.7%) |
| Mar 1999 | - | -$2.70 M(-3.6%) | -$10.70 M(-20.1%) |
| Dec 1998 | -$13.40 M(-297.1%) | -$2.80 M(+3.7%) | -$13.40 M(-518.8%) |
| Sept 1998 | - | -$2.70 M(+8.0%) | $3.20 M(-420.0%) |
| June 1998 | - | -$2.50 M(-53.7%) | -$1.00 M(-114.9%) |
| Mar 1998 | - | -$5.40 M(-139.1%) | $6.70 M(-1.5%) |
| Dec 1997 | $6.80 M(-161.3%) | $13.80 M(-300.0%) | $6.80 M(-166.7%) |
| Sept 1997 | - | -$6.90 M(-232.7%) | -$10.20 M(+75.9%) |
| June 1997 | - | $5.20 M(-198.1%) | -$5.80 M(-58.3%) |
| Mar 1997 | - | -$5.30 M(+65.6%) | -$13.90 M(+25.2%) |
| Dec 1996 | -$11.10 M(+29.1%) | -$3.20 M(+28.0%) | -$11.10 M(+40.5%) |
| Sept 1996 | - | -$2.50 M(-13.8%) | -$7.90 M(+46.3%) |
| June 1996 | - | -$2.90 M(+16.0%) | -$5.40 M(+116.0%) |
| Mar 1996 | - | -$2.50 M | -$2.50 M |
| Dec 1995 | -$8.60 M | - | - |
FAQ
- What is Titan Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly FCF year-on-year change?
- What is Titan Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals TTM FCF year-on-year change?
What is Titan Pharmaceuticals annual free cash flow?
The current annual FCF of TTNP is -$7.09 M
What is the all time high annual FCF for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual free cash flow is $6.80 M
What is Titan Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of TTNP is -$2.07 M
What is the all time high quarterly FCF for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly free cash flow is $13.80 M
What is Titan Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, TTNP quarterly free cash flow has changed by +$178.00 K (+7.93%)
What is Titan Pharmaceuticals TTM free cash flow?
The current TTM FCF of TTNP is -$6.76 M
What is the all time high TTM FCF for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high TTM free cash flow is $7.78 M
What is Titan Pharmaceuticals TTM FCF year-on-year change?
Over the past year, TTNP TTM free cash flow has changed by +$330.00 K (+4.65%)